glp 1 meds oral Eli Lilly Gets Speedy FDA Nod for GLP-1 Drug, a Competitor to New Novo Nordisk Pill Is the Wegovy® Pill &

However, the long-term effects on a patients health beyond the trial timelines and on the costs to the healthcare system are still uncertain

Retatrutide (5mg-10mg), Triple Incretin Receptor Agonist Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Introduction Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Retatrutide is a synthetic 39-residue peptide engineered as a balanced agonist of three distinct class B G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)

No nausea I said 4 only because Ive taken this before through another company

It marks the first time the federal agency has granted approval to an oral GLP-1 receptor agonist drug specifically for weight management